Stockreport

Coya Therapeutics SAB Chairman Dr. Stanley Appel, M.D. Selected as Speaker at the Society of Neuroimmune Pharmacology Conference

Coya Therapeutics, Inc.  (COYA) 
PDF Dr. Appel to discuss the potential of combination immunotherapy in ALS HOUSTON--(BUSINESS WIRE)--Coya Therapeutics, Inc. (Nasdaq: COYA) (“Coya” or the “Company”), a c [Read more]